CRO QbD Clinical adopts BSI’s CTMS software, becomes client ambassador for the Benelux region

BSI announces the adoption of its CTMS and eTMF solutions by CRO QbD Clinical, part of the QbD group. With 11 offices worldwide, the Belgian-based company is a global life sciences partner, supporting MedTech and BioPharma players with ad hoc services “from idea to patient”. And by “global” one should not only understand geographically: The CRO’s team offers a comprehensive set of skills and expertise ranging from regulatory affairs to pharmacovigilance to medical writing. “At QbD Clinical we pride ourselves with solving complex problems,” says Vendor and Strategic Proposal Manager Niels Daems, “however to manage complexity is indeed our day-to-day challenge. To run more than a hundred client projects in parallel requires a highly skilled team and state-of-the-art infrastructure. Here’s where the CTMS and eTMF by BSI Life Sciences come into play,” continues Daems. The software comprehensiveness was a major factor for QbD Clinical’s investment decision, along with the high configurability of the tool. BSI’s eClinical solution is a one-stop shop for clinical trials, allowing Sponsors and CROs to conduct countless studies simultaneously – from planning to close-out. Plus, it integrates well with existing EDC (Electronic Data Capture) and site payment systems. As BSI’s Project Manager Cecilia Ferrari explains, “Clients like QbD Clinical choose our software tool because of its capability to streamline clinical trial operations while still being user-friendly. Running hundreds or even thousands of trials in parallel thus becomes not only possible, but also efficient and a pleasant experience”.

QbD Clinical went live with BSI CTMS and eTMF at the beginning of summer this year, after a configuration workshop and a 3-day training session which took place on site at its offices in Antwerp, Belgium. By joining BSI’s customer reference program, the CRO became an important client ambassador in the Benelux region. “We are enthusiastic about the partnership with BSI Life Sciences and look forward to sharing our CTMS experience with other companies in Belgium and beyond, so that they also get to know the many benefits of BSI’s eClinical tool. It really was a game-changer for us,” remarks Daems. For BSI’s Community Manager Life Sciences Jan Nielsen, the adoption of the software by QbD Clinical validates his company’s strategy to develop comprehensive, yet flexible solutions that tailor to the needs of fast growing CROs and service providers in the Pharma and Biotech space: “We listen to our clients and prospects to build today the product they’ll need tomorrow,” says Nielsen. “This is why we are grateful to Niels [Daems]’s team for representing BSI in its region, allowing us to connect with more and more players in the industry from whom we can learn and improve”.

About QbD Clinical Founded in 2011, QbD Clinical is a full-service CRO providing product development, manufacturing, and clinical trial solutions for companies in the BioPharma, MedTech, In Vitro Diagnostics, and Digital Health industries. Its services include Regulatory Affairs, Quality Assurance, Lab Services, Pharmacovigilance, Provision of Clinical Staffing, Software Validation, and Medical Writing. QbD Clinical is headquartered in Belgium and is part of the QbD group, which has 11 offices in Europe, the US, LatAm and India. In twelve years of operations, more than 500 clients have trusted its services, with over 5,000 projects completed to date.

For more information, please visit: www.qbdgroup.com